Diversified Tracked since Q2 FY26 - Q3 FY26

Divi's Laboratories

Compare with...

DIVISLAB

Latest quarter Q3 FY26

Revenue ₹2,604 Cr

Management credibility Building

Promise tracking available after 2+ quarters of coverage.

View all executive profiles for Divi's Laboratories

Latest signal bullish medium

Divi's Laboratories reported Q3 FY26 PAT of ₹583 crore, broadly flat YoY, impacted by a one-time exceptional charge o...

Guidance tracker

Quarterly Earnings Timeline

Financial verification status, call summary, sentiment, and management-delivery signals by quarter.

2 quarters

Q3 FY26 23 Jan 2026

Revenue ₹2,604 Cr

Divi's Laboratories reported Q3 FY26 PAT of ₹583 crore, broadly flat YoY, impacted by a one-time exceptional charge of ₹74 crore due to labor code changes.

bullish medium

3 missed Read full analysis →

Q2 FY26 30 Oct 2025

Revenue ₹2,715 Cr

Divi's Laboratories reported a strong Q2 FY26 with PAT of ₹689 crore, up 35% YoY, driven by robust custom synthesis (56% of mix) and stable generic volumes despite pri...

bullish high

Scorecard starts after historical backfill Read full analysis →